Evidence map›Paper›PMID 22278293›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2012

Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires' disease.

M Mentasti, N K Fry, B Afshar, C Palepou-Foxley, F C Naik, T G Harrison

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Infection and drug resistance · 2026
    Review
  3. Identification rate ofJournal of clinical microbiology · 2024
    Article
  4. Severe Legionnaires' disease.Annals of intensive care · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Non-IDCases · 2022
    Article
  10. New Insight regardingMicrobiology spectrum · 2021
    Article
  11. Occurrence ofPathogens (Basel, Switzerland) · 2021
    Article
  12. How Molecular Typing Can SupportInternational journal of environmental research and public health · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Advances inPathogens (Basel, Switzerland) · 2019
    Article
  17. Article
  18. Article
  19. Low genomic diversity of Legionella pneumophila within clinical specimens.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2018
    Article
  20. Epidemiological information is key when interpreting whole genome sequence data - lessons learned from a largeEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M MentastiRespiratory and Systemic Infection Laboratory, Microbiological Services Division, Health Protection Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.
N K Fry
B Afshar
C Palepou-Foxley
F C Naik
T G Harrison

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of Legionella pneumophila DNA in clinical specimens using quantitative real-time polymerase chain reaction (qPCR) combined with direct sequence-based typing (SBT) offers rapid confirmation and timely intervention in the investigation of cases of Legionnaires' disease (LD). We assessed the utility of a specific L. pneumophila qPCR assay targeting the macrophage infectivity potentiator (mip) gene and internal process control with three clinical specimen types from confirmed LD cases. The assay was completely specific for L. pneumophila, as demonstrated by positive results for 39/39 strains from all subspecies and 16 serogroups. No cross-reaction was observed with any of the 54 Legionella non-pneumophila (0/69 strains) or 21 non-Legionella (0/58 strains). All L. pneumophila culture-positive respiratory samples (81/81) were qPCR-positive. Of 80 culture-negative samples tested, 47 (58.8%) were qPCR-positive and none were inhibitory. PCR was significantly more sensitive than culture for samples taken ≤ 2 days of hospitalisation (94.7% vs. 79.6%), with the difference being even more marked for samples taken between 3 and 14 days (79.3% vs. 47.8%). Overall, the sensitivity of the qPCR was ∼30% greater than that of culture and direct typing on culture-negative PCR-positive samples resulted in full 7-allele profiles from 23/46, 5 to 6 alleles from 8/46 and ≥ 1 allele from 43/46 strains.

Indexed as

Bacterial ProteinsHumansLegionella pneumophilaLegionnaires' DiseaseMolecular Diagnostic TechniquesMolecular EpidemiologyMolecular TypingPeptidylprolyl IsomeraseReal-Time Polymerase Chain ReactionSensitivity and SpecificityBacterial ProteinsMip protein, Legionella pneumophilaPeptidylprolyl Isomerase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.